Share 'Not sure if this has been posted before. AVI at TIDES Conference.'
May 19, 2009 08:00 ETAVI BioPharma, Inc. to Present at TIDES 2009 Conference
AVI-4658 Therapeutic for Duchenne Muscular Dystrophy Featured in 'Innovation Showcase'
PORTLAND, OR--(Marketwire - May 19, 2009) - AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Peter Sazani, Ph.D., Executive Director of Preclinical Development, is presenting an overview of AVI-…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this